ERANID, European Research Area Network on Illicit Drugs – Towards integrated European research in illicit drugs: cause and nature of drug problems; interventions and policies, FP7
ERANID works both in the demand field and in the supply field. ERANID will promote multidisciplinary research activities in the field of socio-economic sciences and humanities. This may cover e.g. emerging drugs, vulnerable groups, changing demographics of drug using populations, and the impact of drugs on health inequalities and social deprivation. It may also cover patterns in drug markets and the drug-crime nexus. Closer cooperation between researchers in different countries will also lead to a further development of research methodologies, which can be of special importance for the evaluation of policies and programmes. Overcoming fragmentation in drug research and developing a common Strategic Research Agenda (SRA) are key objectives of ERANID. To do this, ERANID will first take stock of research programmes and research projects. By making the results of this exercise easily accessible, ERANID will help researchers and policy makers to find information and avoid unnecessary duplication of research. ERANID will consult stakeholders (e.g. scientific community, treatment centre organisations, patient organisations, police and justice). Analysis of the results will help to find gaps and to set priorities for research that will profit most from an international and interdisciplinary approach. Bringing together funding bodies in EU Member States and other countries, involving policy makers and other stakeholders will help to create consensus about the research priorities. These issues will all inform the SRA, from which the priorities for two joint research calls will be selected. ERANID starts as a consortium of eleven partners from six EU Member States. Other organisations from a number of European and other countries will be kept closely informed and associated to this initiative. ERANID is meant as first step towards a longer term cooperation in the field of drugs research.
Document Type: Research Article
Publication date: May 1, 2017
Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.
- Subscribe to this Title
- Terms & Conditions
- Disseminating research in Impact
- Information about Impact
- Ingenta Connect is not responsible for the content or availability of external websites